
Dr. Marc Siegel explains that unlike COVID, the hantavirus is not expected to lead to sustained community spread due to its limited human-to-human transmission. He highlights ongoing efforts by the U.S. Army, Iowa, the United Kingdom, and Moderna to develop vaccines and therapeutics for the virus.